Cleerly

About

Cleerly is a digital healthcare company that offers heart disease diagnosis solutions.

New York,New York,United States
101 - 250
https://cleerlyhealth.com/

Highlights

Details

Last Funding Type: Series C
Last Funding Money Raised: $223M
Industries: Apps,Artificial Intelligence,Health Care,Medical,Wellness
Founded date: Jan 1, 2017
Number Of Employee: 101 - 250
Operating Status: Active
Legal Name: Cleerly, Inc.

Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway.

Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

3

$280.48M

Cleerly has raised a total of $280.48M in funding over 2 rounds. Their latest funding was raised on Jul 25, 2022 from a Series C round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 25, 2022	Series C	$223M	14	Fidelity Management and Research Company T. Rowe Price	—	Detail
Jun 21, 2021	Series B	$43M	7	Vensana Capital	—	Detail
Aug 10, 2017	Series A	$14.48M	—	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

3

17

Cleerly is funded by 17 investors. Fidelity Management and Research Company and T. Rowe Price are the most recent investors.

Investor Name	Lead Investor	Funding Round
Fidelity Management and Research Company	Yes	Series C
T. Rowe Price	Yes	Series C
Breyer Capital	—	Series C
Cigna Ventures	—	Series C
DigiTx Partners	—	Series C
LRVHealth	—	Series C
Mirae Asset Capital	—	Series C
New Leaf Ventures	—	Series C
Novartis	—	Series C
Peter Thiel	—	Series C